Altimmune, Inc. (ALT)
4.085
-0.10
(-2.51%)
USD |
NASDAQ |
Jan 08, 16:00
4.12
+0.04
(+0.86%)
After-Hours: 19:51
Altimmune Research and Development Expense (Annual): 81.99M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Viking Therapeutics, Inc. | 101.64M |
| Amgen, Inc. | 5.676B |
| Seres Therapeutics, Inc. | 61.87M |
| Rhythm Pharmaceuticals, Inc. | 237.25M |
| Terns Pharmaceuticals, Inc. | 70.11M |